Showing 981-990 of 10251 results for "".
Journal Club: Atopic Dermatitis Control Tool
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-atopic-dermatitis-control-tool/26734/Peter Lio, MD, talks with Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist practicing in Boise, Idaho, about the Atopic Dermatitis Control Tool (ADCT). Highlighted in a recent study published in the British Journal of Dermatology, the ADCT has been said to provide patienBPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianOral Vitamin D Supplementation and Psoriasis Severity
https://practicaldermatology.com/columns/research-reports/oral-vitamin-d-supplementation-and-psoriasis-severity/24213/In the 2023 study by Jenssen et al. entitled, “Effect of Vitamin D Supplementation on Psoriasis Severity in Patients with Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial,” high-dose oral vitamin D supplementation was not found to have a significant effect on psoriasis severSystemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know?
https://practicaldermatology.com/topics/infections-infectious-disease/systemic-corticosteroids-chronic-inflammatory-skin-disease-and-covid-19-what-do-we-know/23615/An assessment of the risk of COVID-19 infection imposed by systemic corticosteroid use in the setting of chronic inflammatory skin disease.DermWireTV: Qwo Approved, Assessing Resident Anxiety
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-qwo-approved-assessing-resident-anxiety/19830/FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. AlleSpecial Report: COVID-19: Surgeons Support Front Lines, How to Cope
https://practicaldermatology.com/topics/practice-management/special-report-covid-19-surgeons-support-front-lines-how-to-cope/19757/The AAFPRS calls on surgeons to consider donating PPE and supplies like ventilators and beds, as nurses call for more preparation for COVID-19. Experts offer strategies for coping with the current environment and planning ahead. Although the AAD Annual Meeting has been cancelled, voting for new offiStatins and Skin Cancer: The Latest Data
https://practicaldermatology.com/topics/skin-cancer-photoprotection/statins-and-skin-cancer-the-latest-data/20426/A look at another commonly used drug and its potential association with skin cancer risks.Journal Club: Blocking IL-4/IL-13 vs JAK/STAT
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-blocking-il-4il-13-vs-jakstat/29101/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Editorial Board member Peter Lio, MD, about the Journal of Personalized Medicine article, "Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?"Science of Skincare Summit 2024: Grab-Bag- Current Topics in Derm
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-grab-bag-current-topics-in-derm/29453/Jennifer Soung, MD, an assistant professor of dermatology at Baylor College of Medicine, and Raja Sivamani, MD, MS, a dermatologist at University of California Davis, join Drs. Todd Schlesinger, James Del Rosso, DO, and Neal Bhatia, MD, for a short discussion about a number of current topics in dermTreating Non-melanoma Skin Cancer: What’s New and Exciting
https://practicaldermatology.com/conferences/scale-2023/treating-non-melanoma-skin-cancer-whats-new-and-exciting/20201/Dermatologists have a host of new tools for treating advanced basal and squamous cell carcinomas. Todd Schlesinger, MD, discusses hedgehog pathway inhibitors and immunotherapy and their growing role in treating non-melanoma skin cancers.